Financial Gravity Companies’s Takeda Pharmaceutical TAK Stock Holding History

Financial Gravity Companies’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.96K	Buy	+148	New	+$2.03K	﹤0.01%	766

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Financial Gravity Companies's TAK Position: Q4 2024 in Review

Financial Gravity Companies opened a new position in Takeda Pharmaceutical (TAK) in Q4 2024: 148 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings.

299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Financial Gravity Companies held 148 shares of Takeda Pharmaceutical worth $1.96K as of Q4 2024.
Takeda Pharmaceutical was a new Financial Gravity Companies position in Q4 2024.
Takeda Pharmaceutical made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2024, its #766 holding.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Financial Gravity Companies's 13F filing for Q4 2024, filed 14 Feb 2025.